(Q47911866)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Kwang-Hyub Han

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

6

Chae Yoon Chon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

8

Jinsil Seong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Hana Park

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Seung Up Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jun Young Park

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Do Young Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

29 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

313-321

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

Challenge and hope in radiotherapy of hepatocellular carcinoma

6 March 2020

cites work

1 reference

Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma

21 January 2018

1 reference

High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.

21 January 2018

1 reference

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

21 January 2018

1 reference

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma

21 January 2018

1 reference

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

21 January 2018

1 reference

Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis

21 January 2018

1 reference

Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients.

21 January 2018

1 reference

Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis

21 January 2018

1 reference

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

21 January 2018

1 reference

Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study

21 January 2018

1 reference

Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma.

21 January 2018

1 reference

Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection

21 January 2018

1 reference

Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma

21 January 2018

1 reference

Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration

21 January 2018

1 reference

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers

21 January 2018

1 reference

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23895043%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference